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Original Article
Expression of innate immune genes,
proteins and microRNAs in lung tissue of
pigs infected experimentally with
influenza virus (H1N2)
Kerstin Skovgaard1, Susanna Cirera2, Ditte Vasby1,*,
Agnieszka Podolska2,y, Solvej Ø Breum3, Ralf Du¨rrwald3,
Michael Schlegel4 and Peter MH Heegaard1
Abstract
This study aimed at providing a better understanding of the involvement of innate immune factors, including miRNA, in
the local host response to influenza virus infection. Twenty pigs were challenged by influenza A virus subtype H1N2.
Expression of microRNA (miRNA), mRNA and proteins were quantified in lung tissue at different time points after
challenge (24 h, 72 h and 14 d post-infection (p.i.). Several groups of genes were significantly regulated according to time
point and infection status including pattern recognition receptors (TLR2, TLR3, TLR7, retinoic acid-inducible gene I,
melanoma differentiation associated protein-5), IFN and IFN-induced genes (IFN-b, IFN-g, IRF7, STAT1, ISG15 and
OASL), cytokines (IL-1 b, IL-1RN, IL-6, IL-7, IL-10, IL-12A, TNF-a, CCL2, CCL3 and CXCL10) and several acute
phase proteins. Likewise, the following miRNAs were differentially expressed in one or more time groups compared
with the control pigs: miR-15a, miR-21, miR-146, miR-206, miR-223 and miR-451. At d 1 p.i. lung tissue protein levels of
IL-6, IL-12 and IFN-a were significantly increased compared with the control group, and haptoglobin and C-reactive
protein were significantly increased at d 3 p.i. Our results suggest that, in addition to a wide range of innate immune
factors, miRNAs may also be involved in controlling acute influenza infection in pigs.
Keywords
H1N2, influenza, innate, miRNA, pig
Date received: 18 October 2012; revised: 20 November 2012; accepted: 11 December 2012
Introduction
Swine inﬂuenza is a highly infectious respiratory disease
in pigs caused by inﬂuenza A virus. Swine inﬂuenza
poses a major problem in agricultural settings with
severe eﬀects on both animal welfare and production
economy. Infection with swine inﬂuenza A virus causes
a number of symptoms, including fever, coughing,
nasal discharge, dyspnoea, decreased appetite and
mass loss, and is further characterized by high morbid-
ity (up to 100%) and low mortality (< 5%).1,2 The
H1N2 swine inﬂuenza virus, reported for the ﬁrst
time in the UK in 1995, spread to pig populations in
European mainland countries during the 1990s.3–5
However, another reassortant H1N2 virus (used as
infectious agent in the present study) with an avian-
like swine inﬂuenza virus H1N1 HA and a European
H3N2 swine inﬂuenza virus-like NA, has been
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circulating in Danish pig populations since 2003.
Recently, this reassortant was also detected in Sweden
and Italy.6–8
The pig has been proposed as an animal model for
human inﬂuenza as the anatomy and physiology of the
porcine respiratory tract are more similar to humans
than these characteristics in rodent models.9–11
Cytokine response proﬁles in inﬂuenza-infected pigs
have also been shown to resemble proﬁles found in
nasal lavage and serum of humans with inﬂuenza A
infection.2,12 Nevertheless, diﬀerences exist, including
the large number of pulmonary intravascular macro-
phages found in pigs,13 implying that further research
is needed in order to fully elucidate the potential of the
pig as an animal model of human inﬂuenza.
Infection with swine inﬂuenza virus is limited to the
respiratory tract. The presence and replication of swine
inﬂuenza virus H1N1 and H1N2 have been reported in
bronchial and bronchiolar epithelial cells of pigs.14–17 A
frontline of pattern recognition receptors (PRRs)
expressed by epithelial cells and other cells of the
respiratory tract activates the innate immune system
after recognition of invading virus. Swine inﬂuenza
virus recognition is operated primarily by two classes
of PPRs: the membrane-bound TLRs and the cytoplas-
mic receptors, such as retinoic acid-inducible gene I
(RIG-I)-like receptors and melanoma diﬀerentiation
associated protein-5 (MDA5). TLR3 and TLR7, both
located within intracellular endosomes, have been
found to play an important role in inﬂuenza A virus
recognition and initiation of the immune response in
human respiratory epithelial cells and plasmacytoid
dendritic cells.18,19 Activation of both the TLRs and
the cytoplasmic receptors leads to a potent type 1
IFN release and simultaneous pro-inﬂammatory cyto-
kine expression. Type 1 IFNs, IFN-g and pro-inﬂam-
matory cytokines, such as IL-1, IL-6, IL-8, IL-12 and
TNF-a, have been shown to be up-regulated in lung
tissue and lung lavage after experimental infection of
pigs with swine inﬂuenza virus.1,2,16,20,21
Although adaptive immune mechanisms are needed
for complete clearance of swine inﬂuenza virus, high
genetic variability due to antigenic drift and gene reas-
sortment makes it possible for swine inﬂuenza virus to
escape previously acquired immunity. Thus, the innate
immune response is pivotal for protection until the
establishment of speciﬁc immunity in the form of pro-
tective Abs and cytotoxic T lymphocytes. A transient
induction of cytokines is required for this eﬃcient anti-
viral defence. However, an over-reactive and prolonged
pro-inﬂammatory response may lead to excessive inﬁl-
tration of immune cells, contributing to immunopathol-
ogy of the infected lung.22–25 Thus, this response must
be tightly regulated. Recently, microRNA (miRNA)
has been proposed to play an important role in mod-
ulating and ﬁne-tuning the innate immune response in
order to avoid such harmful overreactions.26–28
miRNA are small, non-coding RNA molecules (18–
23 nt), that regulate gene expression in a wide range of
organisms.29 miRNA, incorporated into the RNA-
induced silencing complex, binds to the 30 untranslated
regions (UTRs) of speciﬁc targeted mRNAs leading to
mRNA degradation or to repression of translation of
the targeted mRNA transcript to protein.30,31 Recent
results suggest that cellular miRNAs are centrally
involved in inﬂuenza infection, both by targeting
immune-related host transcripts and by targeting
viral gene products.27,32–34 Analysis of miRNA expres-
sion in lung tissue of macaques infected with the highly
pathogenic H5N1 avian inﬂuenza virus and another
group of macaques infected with a less pathogenic
H1N1 virus revealed several miRNAs to be expressed
according to the infective viral strain.35 Host-encoded
miRNA has been shown to target the infecting
virus as reported by Song et al.32 in 2010; they found
miR-323, miR-491 and miR-654 to inhibit the replica-
tion of H1N1 in infected MDCK cells through binding
to the conserved region of the PB1 gene of the inﬂuenza
virus.
Still, little is known about the signiﬁcance of miRNA
regulation in the lung during acute inﬂuenza A infec-
tion. The present work aims to provide a better under-
standing of the involvement of innate immune factors,
including miRNA, in the host response to establish-
ment and progression of inﬂuenza virus infection.
Twenty pigs were challenged by aerosols containing
H1N2 (A/sw/Denmark/12687/03) inﬂuenza virus.
Expression of mRNA coding for cytokines, chemo-
kines, PRRs and other antiviral eﬀector molecules
was quantiﬁed, as were miRNA and protein levels of
IFN-a, IL-1b, IL-6, IL-12A, haptoglobin (Hp), and
C-reactive protein (CRP) in lung tissue sampled at dif-
ferent time points: 24 h post-infection (p.i.), 72 h p.i.
and 14 d p.i.
In agreement with other inﬂuenza studies (H1N1,
H1N2) in pigs,1,2,21,36 we found an early and substantial
immunological response characterized by a strong and
transiently increased expression of pro-inﬂammatory
cytokines, interferons, chemokines, PRRs and acute
phase proteins (APPs) in the lung of swine inﬂuenza
H1N2 virus-infected pigs. Furthermore, our results
demonstrate a signiﬁcant regulation of several host
miRNAs in these pigs.
Materials and methods
Experimental design
Pigs (cross-bred Large WhiteGerman Landrace)
used in the present study were seronegative against
swine inﬂuenza A viruses H1N1, H3N2 and H1N2
(tested against the following strains by haemagglutin-
ation inhibition assay: A/sw/Haselu¨nne/IDT2617/03
H1N1, A/sw/Bakum/1832/00 H1N2, A/sw/Bakum/
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IDT1769/03 H3N2, A/sw/Denmark/13850/03 H1N1,
A/sw/Denmark/12687/03 H1N2). Pigs were challenged
by simultaneous aerosol exposure of 6 l culture super-
natant containing 104.5 TCID50/ml of the Danish H1N2
reassortant virus (A/sw/Denmark/12687/03). Nasal
swab samples from all infected animals were collected
just before infection and at d 1, 3, 5, 7 and 14 after
challenge. Infected animals were euthanized at 24 h
p.i. (n¼ 6), 72 h p.i. (n¼ 6) and 14 d p.i. (n¼ 8). The
ﬁve non-infected control animals were euthanized at
the same time as the 14 d p.i. group. Lung samples
(500mg) from the left cranial lobe of all animals were
stabilized immediately after sampling in RNAlater
(Qiagen, Hilden, Germany), and stored at 20C
until extraction of total RNA and protein. Lung sam-
ples were taken from regions without lung gross lesions.
Evaluation of clinical symptoms
After challenge, clinical symptoms and rectal body
temperature were recorded morning and afternoon
until d 3 p.i. Characterization of clinical symptoms
was based on the following dyspnoea score:
0¼ breathing unaﬀected; 1¼ increased respiratory fre-
quency and moderate ﬂank movement; 2¼marked
pumping breathing and severe ﬂank movement;
3¼ laboured breathing aﬀecting the entire body, pro-
nounced ﬂank movement and substantial movements
of the snout, 4¼ severe breathing reﬂecting substantial
lack of oxygen.
Detection of viral RNA in lung tissue and nasal swab
samples
Total RNA was extracted from 30mg lung tissue or
200 ml of nasal swab samples by RNeasy Mini Kit
(Qiagen) according to manufacturer’s procedure.
Inﬂuenza A virus was detected by an in-house version
of the PriProET assay detecting the matrix gene.37
RNA extraction from lung tissue
Approximately 20–30mg of RNAlater (Qiagen)-stabi-
lized lung tissue was homogenized in 1ml QIAzol Lysis
Reagent (Qiagen) using a gentleMACSTM Dissociator
machine (Milteny Biotec, GmbH, Bergisch Gladbach,
Germany). Total RNA was extracted using miRNeasy
Mini Kit (Qiagen), and all samples were treated with
RNase-free DNase (Qiagen), according to the manufac-
turer’s instructions. The purity of extracted total RNA
was assessed based on UV absorption spectra, includ-
ing OD 260/280 and OD 260/230 ratios on a Nanodrop
ND-1000 spectrophotometer (Saveen and Werner AB,
Limhamn, Sweden). Total RNA was quantiﬁed at OD
260. RNA integrity was measured on an Agilent 2100
Bioanalyzer (Agilent Technologies, Nærum, Denmark)
using the RNA 6000 Nano Kit.
Primer design and optimization (mRNA)
Porcine primers were designed using Primer3 (http://
frodo.wi.mit.edu/) as described in Skovgaard et al.
2009,38 and synthesized at TAG Copenhagen
(Copenhagen, Denmark). Primer sequences, amplicon
length and reaction eﬃciency are shown in
Supplementary Table S1. Primers were designed over
introns if possible, and BLAST searches (http://blas-
t.ncbi.nlm.nih.gov/Blast.cgi) were performed to ensure
the absence of intraspecies polymorphisms at the
primer site. Primer ampliﬁcation eﬃciencies and
dynamic ranges were acquired from standard curves
constructed from several separate dilution series of
pooled cDNA: dilution 1:3, 1:30, 1:300, 1:3000 and
1:30000. Melting curves and agarose gel electrophoresis
of amplicons were performed to certify primer speciﬁ-
city, and selected amplicons were sequenced for further
conﬁrmation. For several genes of interest two or three
primer pairs, annealing at diﬀerent sites at the mRNA
transcript, were designed.
cDNA synthesis and pre-amplification (mRNA)
Extracted RNA was converted into cDNA by reverse
transcription of 500 ng total RNA using the
QuantiTECT Reverse Transcription kit (Qiagen), con-
taining a mix of random primers and oligo-dT, accord-
ing to the manufacturer’s instructions. Two separate
cDNA reactions were performed for each sample.
Non-reverse transcriptase controls were prepared.
cDNA was diluted 1:6 in low EDTA TE-buﬀer (VWR
– Bie & Berntsen, Herlev, Denmark) prior to pre-ampli-
ﬁcation. Pre-ampliﬁcation was done using TaqMan
PreAmp Master Mix (Applied Biosystems, Foster
City, CA, USA) in the following way. A 200-nM com-
bined primer mix was prepared combining all primers
used in the present study. TaqMan PreAmpMaster Mix
(5 ml) was mixed with 2.5 ml of 200 nM combined primer
mix and 2.5 ml of diluted cDNA, and incubated at 95C
for 10min, followed by 15 cycles of 95C at 15 s and
60C at 4min. Pre-ampliﬁed cDNA was diluted at
least 1:4 in low EDTA TE-buﬀer (VWR – Bie &
Berntsen) before quantitative real-time PCR (qPCR).
qPCR (mRNA)
qPCR was performed in the 48.48 Dynamic Array
Integrated Fluidic Circuits (Fluidigm, CA, USA,
USA) combining 48 pre-ampliﬁed samples with 48
primer sets for 2304 individual and simultaneous
qPCR reactions. The following reagents were used for
48 reactions of pre-sample mix: 3 ml of ABI TaqMan
Gene Expression Master Mix (Applied Biosystems),
0.3 ml of 20X DNA Binding Dye Sample Loading
Reagent (Fluidigm), 0.3 ml of 20X EvaGreen
(Biotium; VWR – Bie & Berntsen), 0.9 ml low EDTA
TE Buﬀer (VWR – Bie & Berntsen) and 1.5 ml diluted
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pre ampliﬁed cDNA. Primer mixes were prepared using
2.3 ml of 20 mM forward and reverse primers (see
Supplementary Table S1), 2.5 ml of 2X Assay Loading
Reagent (Fluidigm) and 0.2ml of low EDTA TE-buﬀer
(VWR – Bie & Berntsen). The 48.48 Dynamic Array
was primed in the IFC controller (Fluidigm) prior to
loading of sample and primer. Sample mix, including
cDNA (5ml) and primer mix (5 ml) was dispensed into
appropriate inlets and loaded into the chip in the IFC
Controller, combining each of the 48 samples with 48
primers in 2304 separate reactions. The chip was then
placed in the BioMark real-time PCR instrument
(Fluidigm) and the following cycle conditions were
used: 2min at 50C and 10min at 95C, followed by
35 cycles with denaturation for 15 s at 95C and anneal-
ing/elongation for 1min at 60C. Melting curves were
generated after each run to conﬁrm a single PCR prod-
uct (from 60C to 95C, increasing 1C/3 s).
Reactions were performed in duplicate (cDNA repli-
cates). Non-template controls were included to indicate
potential problems with non-speciﬁc ampliﬁcation or
sample contamination. Non-reverse transcriptase con-
trols were included to assess potential DNA contamin-
ation. Relative concentrations of target mRNA were
assigned using standard curves constructed from 3 sep-
arate dilution series of pooled cDNA of equal amounts
of all samples: dilution 1:3, 1:30, 1:300, 1:3000, 1:30,000.
Data were acquired using the Fluidigm Real-Time PCR
Analysis software 3.0.2 (Fluidigm).
cDNA synthesis and qPCR (miRNA)
Reverse transcription of 1 mg total RNA was performed
according to the manufacturer’s instructions (miScript;
Qiagen). qPCR was performed on a Rotor-Gene 3000
(Corbett Research, Sydney, Australia) in 20 ml total
volume with 1 ml of cDNA diluted 10–15 times, 10 ml
of 2 x Quantitect SYBR Green PCR master mix
(Qiagen), 1 ml of universal primer (Qiagen), 1 ml of
10 mM miRNA-speciﬁc primer and 7 ml of miliQ-
water. Each run included a no-template control and
standard curves with ﬁvefold dilutions to calculate
qPCR eﬃciency. Primer sequences and eﬃciency for
each assayed miRNA gene are listed in
Supplementary Table S2. Cycling conditions were
95C for 15min followed by 40 cycles of 15 s at 94C,
30 s at 55C and 30 s at 72C. A melting curve analysis
(60–99C) was performed after 40 cycles. Using the
same total RNA samples, a second highly speciﬁc
cDNA synthesis and qPCR method described recently
by Balcells et al.39 was used in order to improve the
robustness of the miRNA dataset.
Protein extraction from lung tissue
Protein extraction was performed on tissue from the
left cranial lobe of all animals, the same tissue as for
the RNA extraction. Brieﬂy, homogenization was per-
formed using 0.2–0.5 g of tissue in 1ml buﬀer [0.1M
Tris/HCl pH 7.2, 0.1M NaCl, plus protease inhibitor
cocktail Complete Ultra from Roche (1 tablet per 10ml
buﬀer)] per 100mg tissue using a GentleMacs
Dissociator (Miltenyi Biotec). The homogenization
was followed by incubation on a rocking table for
18 h (overnight) at 4C. Finally, samples were centri-
fuged for 20min at 10,000 g and the supernatant was
retrieved and used for analysis of APPs and cytokines
by ELISA.
Cytokine detection by ELISA
CRP was analysed in lung tissue extracts by a sand-
wich-type ELISA using dendrimer-coupled cytidine
diphosphocholine (a CRP-binding ligand) in the coat-
ing layer, as described in Heegaard et al.,40 employing
polyclonal rabbit anti-human Abs with cross-reactivity
towards porcine CRP followed by peroxidase-conju-
gated goat anti-rabbit Ab for detection [both Abs
from DAKO (Glostrup, Denmark)]. The cross-reactiv-
ity of the anti-human CRP Ab with pig CRP was
demonstrated previously,41 and combining it with
diphosphocholine ensures speciﬁcity for CRP.
Combined pig serum calibrated against a human CRP
calibrator (DAKO A0073, DAKO) was used as stand-
ard. The detection limit was 35 ng/ml (human equiva-
lents). Hp in lung tissue extracts was determined by a
sandwich ELISA using an in-house mouse anti-porcine
Hp monoclonal Ab in the coating layer and biotiny-
lated commercial rabbit anti-human haptoglobin
(DAKO A0030; DAKO) as the detection Ab, as
described previously,42 with a detection limit of
0.13mg/ml for the tissue extracts. CRP and Hp plates
were developed with a tetramethylbenzidine (TMB)
peroxide color substrate from Kem-En-Tec (Taastrup,
Denmark), following the manufacturer’s instructions.
The ODs of wells were measured at 450 nm, subtracting
unspeciﬁc colouration at 650 nm using an automatic
plate reader (ThermoMultiskan Ex spectrophotometer;
Thermo Scientiﬁc, Waltham, MA, USA). All samples,
including standards, were measured in duplicate.
Sample values were calculated from the curve ﬁtted to
the readings of the standard (using Ascent software v.
2.6; Thermo Scientiﬁc).
IL-6, IL-1b and IL-12A lung tissue concentrations
were determined by ELISAs from R&D Systems
(Duoset DY686, Duoset DY681, and Duoset DY912
respectively) using goat anti-pig IL-6/IL-1b/IL-12A
for catching and biotinylated goat anti-pig IL-6/IL-
1b/IL-12A for detection, and also including a porcine
IL-6/IL-1b/IL-12A standard respectively. Development
of plates was done with a TMB peroxide colour sub-
strate from Kem-En-Tec, following the manufacturer’s
instructions. Samples were run in duplicate at a dilution
of 1:2 with a detection limit of 31.3 pg/ml (IL-6 and
4 Innate Immunity 0(0)
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IL-12A) and 15.6 pg/ml (IL-1b). IFN-a was quantiﬁed
by a sandwich ELISA as described by Sorensen et al.43
Brieﬂy, an anti-pig IFN-amonoclonal mouse Ab (clone
K9; PBL Biomedical Laboratories, Piscataway, NJ,
USA) was coated overnight at 4C at 0.2mg/ml in
PBS. The pig IFN-a standard was also from PBL
Biomedical Laboratories (1.66 106U/ml), and this
was applied in a twofold dilution series from 166U/
ml. Samples and standard were incubated for 5 h at
20C (room temperature), followed by wash and incu-
bation overnight at 4C with the biotinylated detection
Ab [mouse monoclonal anti pig IFN-a, clone F17 (PBL
Biomedical Laboratories), biotinylated in-house by
standard procedures]. Finally, plates were incubated
with peroxidase-coupled streptavidin (DAKO) for 1 h
at room temperature and then developed using TMB
Plus substrate from Kem En Tec. The detection limit
was 1.04U/ml.
Lung tissue extract protein data were normalized in
the following way. The extinction at 280 nm was deter-
mined for each sample, samples were normalized indi-
vidually by multiplying with the correction factor:
[E280 (mean, all samples)]/[E280 (sample)]. The detec-
tion limit for all ELISAs was determined as the lowest
concentration in the standard row multiplied by the
dilution factor employed for the samples.
Statistical analysis and target prediction
Data pre-processing, normalization, relative quantiﬁca-
tion and statistics were performed using GenEx5
(MultiD, Go¨teborg, Sweden). Data were pre-processed
as follows. Data were corrected for PCR eﬃciency for
each primer assay individually. For the mRNA data
normalization was done to the mean of ﬁve reference
genes (hypoxanthine phosphoribosyl-transferase 1,
ribosomal protein L13a, peptidylprolyl isomerase A,
TATA box binding protein and tyrosine 3-monooxy-
genase/tryptophan 5-monooxygenase activation pro-
tein, zeta polypeptide) found to be the most stably
expressed reference genes out of seven tested in the pre-
sent study using both GeNorm44 and NormFinder.45
For the miScript miRNA data MiR-107 and miR-664
were validated and used as reference genes. The two
technical cDNA replicates were averaged after normal-
ization. To visualize diﬀerential gene expression for
each gene tested, the mean mRNA expression of the
control animals was assigned the value of 1, and rela-
tive expressions were calculated for the rest of the sam-
ples compared to the control group. Data were log2
transformed for approaching normal distribution
prior to ANOVA and t-test analysis. Gene expression
was considered to be signiﬁcant if the P-value was
< 0.05. An increase or decrease in expression of at
least 2- (mRNA) or 1.5-fold (miRNA) was considered
as biologically signiﬁcant. Gene expression data ﬁtting
both P-value and fold-change criteria were plotted in
bar diagrams. Pearson correlation coeﬃcients (Rho)
were calculated when comparing mRNA and protein
data; Spearman rank correlation was used when com-
paring dyspnoea score with rectal temperature or virus
load.
The prediction of miRNA targets in the present
study was performed using several diﬀerent bioinfor-
matics sources: Target Scan 6.1,46–48 PicTar,49,50
microT51 and Miranda.52 Vertebrate datasets with con-
served target sites were used in Target Scan. The 30
UTRs of human or bovine origin (if possible) were
chosen.
Results
Clinical signs and pathology
All pigs in the infected group developed typical clinical
signs of inﬂuenza. For 19 out of the 20 infected animals
the onset was abrupt, with fever > 40C (39.6C for 1
animal) on d 1 p.i. (Figure 1). Dyspnoea scores were
found to peak at 1.5 d p.i. and then declined gradually
thereafter (Figure 1). A signiﬁcant correlation
(Rho¼ 0.52, P< 0.001) was seen between rectal tem-
perature and dyspnoea score. To further evaluate the
inﬂuenza A virus infection in the animals, virus excre-
tion was measured by analysis of nasal swab samples.
Virus load in nasal swabs collected before and on d 1, 3,
5, 7 and 14 after challenge of infected animals was
found to peak between d 1 and 3 p.i., and to decrease
substantially between d 5 and 7 p.i. (Figure 2). No inﬂu-
enza virus was detected in nasal swabs at d 14 p.i. The
same overall pattern were seen in virus quantiﬁed in
lung tissue at d 1 and d 3; however, more viral RNA
was detected in lung samples compared to nasal swabs
(Figure 2). There was a high correlation between virus
load and dyspnoea score (mean values of the time
groups) within the ﬁrst 3 d (Rho¼ 0.97). Demarcated
dark purple areas of gross lesions were seen in the
apical parts of the apical, cardiac and diaphragmatic
lung lobes of infected animals 3 d p.i., which decreased
until 14 d p.i.; no signs of pathological changes were
seen in lungs from control animals (data not shown).
mRNA expression
Expression levels of mRNA coding for more than 60
diﬀerent genes, including cytokines, chemokines, PRRs
and other antiviral eﬀector molecules, were quantiﬁed
using RT-qPCR. We found several functional groups
of genes to be signiﬁcantly regulated according to time
point and infection status (P< 0.05 and fold change
> 2; see Figure 3a–d), including PRRs (TLR2, TLR3,
TLR7, RIG1, MDA5), IFN and IFN-induced genes
[IFN-b, IFN-g, interferon regulatory factor (IRF) 7,
signal transducer and activator of transcription 1
(STAT1), ISG15 ubiquitin-like modiﬁer (ISG15) and
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20-50-oligoadenylate synthetase-like (OASL)], cytokines
[IL-1b, IL-6, IL-7, IL-10, IL-12A, TNF-a, chemokine
(C-C motif) ligand (CCL) CCL2, CCL3, CXCL10 and
IL-1 receptor antagonist], and APPs [serum amyloid A
(SAA), transferrin (TF), apolipoprotein A-I (APOA1)]
(Figure 3a–d).
Expression of both membrane-bound and cytoplas-
mic PRRs was induced in a time-dependent way
(Figure 3a). The two cytoplasmic PRRs, RIG1 (also
known as DDX58) and MDA5, were two of the most
highly induced PRRs, with RIG1 being up-regulated
more than 60-fold at d 1 compared to the control
pigs. This up-regulation continued until d 3 and con-
tinued at d 14 p.i. with 2-fold up-regulation of RIG1
expression. Nucleotide-binding oligomerization
domain 1 (NOD1) and NLR family pyrin domain-
containing 3 (NLRP3) were not regulated more than
twofold at any time point (data not shown). TLR3
and TLR7, recognizing double- and single-stranded
viral RNA, respectively, were signiﬁcantly up-regulated
at d 1 p.i. and at d 3 p.i. TLR2 was transiently up-regu-
lated, peaking at d 1. Downstream of TLR7 we found
myeloid diﬀerentiation primary response protein 88
(MyD88), IL-1 receptor-associated kinase (IRAK1)
and IRF7 to be signiﬁcantly up-regulated in response
to inﬂuenza virus infection, whereas IRF3 was up-
regulated less than twofold (data not shown). Mean
expression of TLR3, TLR7, RIG1 and MDA5 at d 1,
3 and 14 p.i. was highly correlated with virus load
(Rho¼ 0.92, P¼ 0.04) in nasal swabs. However, only
RIG-1 and MDA5 were signiﬁcantly correlated with
virus load when the assessment was done based on indi-
vidual animal samples rather than mean expression at
the diﬀerent days.
Interestingly, mRNA coding for IFN-a was found
not to be regulated (Figure 3b); however, another type
1 IFN, IFN-b, was highly up-regulated a short time
after infection. Both the IFN-b and the IFN-a data
shown in Figure 3b represent one out of three diﬀerent
primer pairs amplifying diﬀerent sequences of the same
transcript; expression results from all three primer pairs
were highly correlated (data not shown). IFN-g was
found to be transiently up-regulated. In accordance
with the up-regulation of type 1 and type 2 IFN, sig-
niﬁcant up-regulation of the IFN-induced genes
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STAT1, ISG15, CXCL10 and OASL was detected
shortly after inﬂuenza infection (Figure 3b, c).
A group of cytokine genes was strongly induced with
a maximum response at d 1 p.i. (Figure 3c), which
included IL-1b, IL-1RN, IL-6 and IL-12A (mainly
pro-inﬂammatory cytokines), as well as the chemokine
genes CCL2 and CXCL10. Another group of genes,
namely IL-7, IL-10, TNF-a and CCL3, showed the
same response; however, the response was more mod-
erate. Remarkably, both IL-7 and TNF-a displayed
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Figure 3. Gene expression visualized as mean fold change of mRNA levels relative to control samples in log2 scale. SEM is depicted
by error bars. *P< 0.05, **P< 0.01, ***P< 0.001 (ANOVA). Control group (n¼ 5), d 1 p.i. (n¼ 6), d 3 p.i. (n¼ 6) and d 14 p.i. (n¼ 8).
(A) Expression of PRRs and downstream signalling molecules. (B) Expression of IFNs and IFN-induced genes. (C) Expression of
cytokines and chemokines. (D) Expression of acute phase proteins and mucin1 (linear scale).
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relatively short lived responses, and fully returned to
the levels of the controls at d 3 p.i. Both IL-1a and
CXCL8/IL-8 showed a unique response with a moder-
ate decrease of less than twofold at d 3 p.i. (data not
shown). Finally, IL-13 showed a remarkably late
response peaking at d 14 p.i. (P¼ 0.09).
Local expression of several APPs (Figure 3d) was
found in the lungs of inﬂuenza-infected and control
pigs. mRNA coding for SAA and Hp were up-
regulated at d 1 p.i., whereas the two negative APPs
APOA1 and TF were signiﬁcantly down-regulated at
d 1 and d 3 respectively. Expression data with the use
of two diﬀerent primer pairs of TF were found to be
highly correlated (Rho¼ 0.98). The mRNA coding for
CRP could not be quantiﬁed as this primer assay did
not meet the quality criteria described in the Material
and methods. Surprisingly, the positive APP SAA was
found to be signiﬁcantly down-regulated in lung sam-
ples of all 8 animals at d 14 p.i. Transcript coding for
the antimicrobial protein mucin 1 (MUC1) was found
to be up-regulated, whereas the surfactant proteins
SFTPA1 and SFTPD were not aﬀected (data not
shown).
miRNA expression
We found the following miRNAs to be signiﬁcantly
regulated at one or more time point groups compared
with the control pigs: miR-15a, miR-146, miR-206,
miR-223 and miR-451 (Figure 4). Further up-regula-
tion of miR-21 at d 3 was found to be borderline sig-
niﬁcant based on the miScript data (P¼ 0.055), but
signiﬁcant based on the Balcells method (P¼ 0.003)
(see Materials and methods). The response patterns
varied widely, with miR-15a being signiﬁcantly
increased at all time points, including d 14 p.i., miR-
21, miR-206 and miR-451 showing late responses (d
3, 14 and 14 as maximum response respectively) and
miR-223 showing a transient d 1 p.i. response. The
down-regulation of miR-146 was also transient, peak-
ing on d 1 p.i.
Based on in silico miRNA target prediction algo-
rithms, multiple sites in the 30 UTR of PRRs, cytokines
and chemoattractants, found to be regulated in
our study, were predicted targets for the miRNAs
(Figure 4). Interestingly, chemoattractant CXCL10
and several inﬂammatory cytokines were predicted
to be targets of two or more of the investigated
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miRNAs (Figure 4). MiR-15a, miR-206, miR-223 and
miR-451 found to be signiﬁcantly up-regulated after
inﬂuenza A infection were further applied to an
extended search after pro-inﬂammatory targets sites
using the algorithms miRanda and microT. A number
of additional targets sites within pro-inﬂammatory
cytokines and associated molecules were predicted
(see Supplementary Table S3). To establish whether
particular functional groups of genes found to be regu-
lated in the present study were relatively more prone to
be regulated by miRNAs, the mean number of miRNA
target sites per gene was investigated within cytokines,
PRR, APP and MUC1 (Table 1). All three diﬀerent
algorithms (miRanda, TargetScan and PicTar) pre-
dicted that the cytokine group contained the highest
mean number of miRNA target sites compared with
the other groups (Table 1).
Protein concentrations in lung tissue
Protein analysis was performed on the same tissue as
subjected to expression analysis of mRNA and
miRNA. Lung tissue concentration of IFN-a, IL-1b,
IL-6, IL-12A, HP and CRP in pigs slaughtered at 1, 3
and 14 d p.i. can be seen in Figure 5. Several samples
from the control group, as well as from the 14 d p.i.
pigs, were below the limit of detection. At d 1 p.i. pro-
tein levels of the pro-inﬂammatory cytokines IL-6, IL-
12A and IFN-a were signiﬁcantly increased compared
with the control group; likewise, HP and CRP were
signiﬁcantly increased at d 3 p.i., reﬂecting an early
pro-inﬂammatory cytokine response followed by
a later expression of APPs in diseased animals
(Figure 5). Strong correlation was found between IL-
6 and IL-12 protein data and the mRNA expression
data from the same cytokines. The correlation between
IL-1b and HP mRNA and protein was more moderate
(but signiﬁcant), possibly as a result of the missing
protein concentration data in samples below the limit
of detection. No correlation was seen for the IFN-a
protein and mRNA data (see Supplementary Table S4).
Discussion
The inﬂuenza virus-infected pig has been proposed as a
model for human inﬂuenza,16 as pigs are fully suscep-
tible to human inﬂuenza strains, and as the pig has been
demonstrated to be involved in inﬂuenza evolution and
ecology.4,53,54 In the present investigation the develop-
ment of the dyspnoea score in pigs after experimental
H1N2 infection resembled symptom scores in human
volunteers infected experimentally with H1N1.12
Likewise, viral loads were found to peak between d 1
and 3 p. i., as has also been shown in humans,12 con-
ﬁrming the pig as a promising animal model for human
inﬂuenza.
We studied the expression of PRRs, cytokines, APPs
and miRNAs involved in the host response to H1N2
inﬂuenza infection. The invading inﬂuenza virus is
sensed initially by several types of PRRs found on the
surface or within cells of the respiratory system.18,19
Here, the expression of classical virus-speciﬁc endoso-
mal TLR3 and 7 was signiﬁcantly increased at d 1 p.i.
Interestingly, TLR8, which shares ligand speciﬁcities
and cellular location with TLR7 and TLR3, was not
induced signiﬁcantly at any of the time points investi-
gated. The plasma membrane-located TLR2, classically
activated by Gram-positive bacterial ligands was
induced moderately by the swine inﬂuenza virus infec-
tion at d 1 p.i. This conﬁrms earlier observations that
TLR2 may be activated in an endosomal-dependent
fashion,55,56 leading to an antiviral IFN type I
response.
Transcripts coding for the two cytoplasmic PRRs
RIG1 and MDA5 were more up-regulated compared
with the TLRs at d 1 p.i. This might, to some degree,
reﬂect the cell type composition of the sampled lung
tissue, as RIG1 is expressed by a wide variety of cell
types, whereas TLR7 is expressed by a more limited
range of cell types, namely plasmacytoid DC and
macrophages.57 Another cytoplasmic PRR, NOD1,
was not induced (data not shown). This complies well
with the known speciﬁcity of NOD1 for bacterial
molecular structures and the speciﬁcity of RIG1 and
MDA5 for dsRNA, produced upon replication of
RNA viruses. The direct induction of classical bacter-
ium-speciﬁc PRRs by swine inﬂuenza virus in pig lung
tissue, as seen here for TLR2, but not for NOD1, may
contribute to the hyper-responsiveness towards bacter-
ial infections frequently occurring secondarily to viral
infections.58 The correlation established between virus
load and mRNA levels of RIG1 and MDA5 in the lung
tissue of each animal support the importance of these
PRRs in recognition of H1N2 inﬂuenza virus in swine.
TLR7 activates the signalling pathway via MyD88,
resulting in the activation of IRF7. Accordingly, we
found both MyD88 and IRF7 to be signiﬁcantly up-
regulated, whereas IRF3 was only weakly up-regulated
(not shown). This might suggest that the TLR7/MyD88
Table 1. Mean number of miRNA target sites per gene in each
functional group. All genes included in this table were regulated in
response to swine influenza virus infection (SEM in brackets).
Functional group Miranda Target Scan PicTar
Cytokines (n¼ 12)* 26.8 (3.3) 4.2 (1.1) 2.9 (1.3)
Pattern recognition
receptors (n¼ 5)*
17.4 (6.2) 1 (0.8) 0
IRF7, MYD88, IRAK1 (n¼ 3) 12 (6.7) 1.3 (0.7) 1.7 (0.9)
APP and MUC1 (n¼ 4)* 2.75 (1.3) 1.25 (0.75) 0
*Cytokines: IFN-g, IL-1B, IL-1RN, IL-6, IL-7, IL-10, IL-12A, IL-13, TNF-a,
CCL2, CCL3, CXCL10; PRRs: TLR2, TLR3, TLR7, RIG1, MDA5; APPs:
APOA1, SAA, TF.
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pathway predominates in the activation of intracellular
signal cascades, leading to secretion of type I IFN and
pro-inﬂammatory cytokines upon inﬂuenza infection in
swine. In a recent study, Wang et al.25 found RIG1 and
MD5A expression to peak at 4 h p.i. and TLR3 and
TLR7 to peak at 24 h p.i. in H1N1-infected human
alveolar macrophages. We were not able to diﬀerentiate
between early and late PRRs, possibly owing to the
lack of porcine lung tissue sampled at time points ear-
lier than 24 h p.i.
Remarkably, expression of mRNA coding for
IFN- a was not increased at any of the time points
investigated. The lack of regulation was surprising as
(i) IFN-a is a central type I antiviral cytokine, (ii)
IFN-a was found to be strongly induced at the pro-
tein level in lung tissue (see below), (iii) another type
I IFN (IFN-b) was strongly induced and (iv) several
IFN-stimulated genes (ISGs) were, indeed, induced
(IRF7, STAT1, ISG15, OASL, CXCL10). However,
previous data indicate that type I IFN gene induction
may be very cell-type speciﬁc although still capable of
a full-blown induction of systemic type I IFN activ-
ity.59,60 Another possibility is that the IFN- gene is
very transiently induced and has simply returned to
baseline expression at d 1 p.i. as described after CpG
oligodeoxynucleic acid stimulation of porcine blood
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mononuclear cells by Sorensen et al.43 for porcine
IFN-a in cell culture. Type I IFNs (IFN-a and
IFN-b) act by activating NK cells and by inducing
expression of ISGs.57,61,62 Accordingly, Sadler and
Williams63 found several ISGs to be up-regulated
during inﬂuenza infection in pigs. ISG15 and
OASL, also found to be up-regulated in the present
study, are well known inducers of antiviral activity.
Similarly, CXCL10, another highly up-regulated ISG
in the present study, is a potent chemoattractant of
NK cells.64,65 Interestingly, at the protein level, IFN-
a was signiﬁcantly and dramatically (around 100-
fold) increased in the lung tissue of infected pigs at
d 1 p.i., followed by normalization at d 3 p.i. The
same pattern was seen for IL-1b, IL-6 and IL-12A
proteins, although the increases were much smaller.
We found an early and substantial increase of
mRNA levels of IL-1b, IL-6, IL-12A, TNF-a, CCL2,
CCL3 and CXCL10. This is in accordance with other
inﬂuenza studies in pigs1,2,21,36 and in humans.25,66–71
IL-13, a known inducer of alternatively activated
macrophages (AAM), was expressed at its highest
level at day 14 p.i. Changes in the composition of
immune cells several weeks after viral infection, leading
to increased susceptibility to secondary bacterial infec-
tions, have been reported.58,72 In mice, AAM have been
proposed to contribute to hyper-susceptibility to sec-
ondary bacterial infection.73
Many of the up-regulated genes are well known
pro-inﬂammatory cytokines, strongly involved in
local inﬂammation and in induction of the systematic
acute phase response. Even though these pro-
inﬂammatory cytokines and chemokines are pivotal in
controlling the viral infection and in shaping the
adaptive immune response, excessive production by
an overexcited innate immune system might,
indeed, exacerbate the infection.24,25,74,75 Several
chemokines—CCL2 (NK cells and macrophages),
CCL3 (macrophages) and CXCL10 (NK cells)—were
highly up-regulated. A massive inﬂux of NK cells and
macrophages into the diseased lung leads to secondary
waves of pro-inﬂammatory cytokines and increased
immunopathology due to nitric oxide mediated
cytotoxicity.76
To our knowledge, regulation of miRNA expression
has not previously been investigated in inﬂuenza virus-
infected pigs, although a single publication, strictly
based on in silico analysis, suggests the presence of
swine-encoded miRNA that targets the inﬂuenza
virus.77 Recent studies in mice,27 in macaques,35 in
chickens33,34 and in the human alveolar cell line
A54978 imply miRNA to be centrally involved in
inﬂuenza infection. Here, we studied the relative levels
of 10 miRNAs previously reported to play a part in the
immune response to viral infection.34,35,78 Furthermore,
in silico analysis of possible inﬂammatory cytokine–
miRNA connections was performed.
Although miRNA changes were small (below 3.5-
fold) compared with PRRs and cytokines, signiﬁcant
changes were observed for 6 of the 10 miRNAs studied,
with miR-146 being down-regulated and the others
being up-regulated following diﬀerent kinetics. Of the
5 up-regulated miRNAs, miR-21 and miR-223 have
also been described as being up-regulated in lung
tissue of both macaques and mice within 5 d of inﬂu-
enza virus infection.35 In addition, miR-21 has previ-
ously been associated with lung inﬂammation of mice.79
Both miR-15a and miR-21 were predicted to target
CXCL10, which could suggest that these miRNAs are
involved in the down-regulation of CXCL10 from d 1
to d 14 p.i.
A twofold down-regulation of miR-146 was seen at d
1 p.i., followed by a return to normal levels at d 3 and
14 p.i. Six target genes putatively regulated by this
miRNA were all increased at d 1 p.i. and, with the
exception of IRAK1, much less increased at d 3 p.i.
This suggests that miR-146 might be involved in
down-regulating transcription of these target genes in
the normal, non-infected pig lung. In contrast, miR-15a
was increased at all time points after infection; how-
ever, both of its target genes were also increased (mod-
erately for TLR7 and strongly for CXCL10). This
indicates that miR-15a may not be involved in the
observed regulation of TLR7 and CXCL10 mRNA
levels, or that this miRNA acts through repression of
mRNA translation to protein, although we have no
data to support this notion. In addition, concurrent
up-regulation of miRNA and its target mRNA may
also occur in order to control critically high levels of
the mRNA. As all targets predicted are based on in
silico analysis, future functional studies should be
given high priority. Although increased with diﬀerent
kinetics, parallel expression was also seen for the rest of
the increased miRNAs and their target genes, which
were also increased, at least at d 1 p.i. Generally, the
target mRNA transcripts predicted for the regulated
miRNAs were associated with inﬂammatory responses,
some of which were, indeed, conﬁrmed as regulated in
the present study. In addition, targets were predicted in
receptors for IL-1, IL-6 and IL-12.
It was also investigated whether the group of regu-
lated cytokines found in the present study might have
an increased probability of being prone to miRNA
regulation by containing a high number of miRNA
target sequences in their mRNA transcripts. This was
done by in silico target prediction and it was shown that
the cytokine group had the highest number of predicted
targets compared with both PRR and APP groups,
using three diﬀerent target prediction algorithms. This
further supports the idea that miRNAs are centrally
involved in the ﬁne-tuning of a robust, but transient,
innate response towards inﬂuenza infection, accom-
plished, to a certain extent, by regulation of pro-inﬂam-
matory cytokines and chemokines in pigs.
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Finally, expression of several positive (CRP, HP,
SAA) and negative (TF and APOA1) APPs and their
coding transcripts was demonstrated in lung tissue of
infected and control pigs. Positive APPs (HP and
SAA) and MUC1 were moderately up-regulated at d
1 p.i., and negative APPs APOA1 and TF were signiﬁ-
cantly down-regulated at d 1 and 3 p.i. respectively.
SAA expression was strongly down-regulated at d
14 p.i. compared with the control group, integrating
data from three highly correlated diﬀerent primer pairs
targeting several isotypes of SAA. Studies of PRRs,
cytokines and APPs weeks after viral clearance might
further elucidate the involvement of late, long-term
gene regulation in susceptibility to secondary infections.
At the protein level, HP and CRP were increased sig-
niﬁcantly at d 3 p.i., although changes were small. Few
studies have explored the expression of APP during inﬂu-
enza infection; however, in two recent studies, CRP and
HP were found to peak 2–3 d after infection in alveolar
lavage ﬂuid and serum of H1N1 infected pigs,2 and CRP,
HP and SAA were increased in serum of H1N2-infected
pigs,80 in accordance with the present study. Even though
the liver is the major producer of APP, extra-hepatic
expression has been demonstrated in several diﬀerent tis-
sues, including lung tissue in pigs experimental infected
with Actinobacillus pleuropneumoniae.38,81
Conclusions
In the present study we investigated the involvement of
innate host immune factors, including miRNA, in the
response to experimental high-dose aerosol H1N2 infec-
tion in pigs. Our results demonstrate a signiﬁcant regu-
lation of several miRNAs, their targeted mRNA and
resulting protein in the lung tissue of pigs during acute
inﬂuenza infection. Future functional studies of carefully
selected miRNAs are planned to reveal their role, both
locally and systematically, in regulating and ﬁne-tuning
the innate immune response during inﬂuenza infection.
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